• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

减重手术与非酒精性脂肪性肝病向肝硬化的进展减少相关:一项回顾性队列分析。

Bariatric Surgery is Associated With Decreased Progression of Nonalcoholic Fatty Liver Disease to Cirrhosis: A Retrospective Cohort Analysis.

机构信息

Department of Surgery, University of Minnesota, Minneapolis, MN.

OptumLabs Visiting Fellow, Cambridge, MA.

出版信息

Ann Surg. 2020 Jul;272(1):32-39. doi: 10.1097/SLA.0000000000003871.

DOI:10.1097/SLA.0000000000003871
PMID:32224733
Abstract

OBJECTIVE

This study sought to compare trends in the development of cirrhosis between patients with NAFLD who underwent bariatric surgery and a well-matched group of nonsurgical controls.

SUMMARY OF BACKGROUND DATA

Patients with NAFLD who undergo bariatric surgery generally have improvements in liver histology. However, the long-term effect of bariatric surgery on clinically relevant liver outcomes has not been investigated.

METHODS

From a large insurance database, patients with a new NAFLD diagnosis and at least 2 years of continuous enrollment before and after diagnosis were identified. Patients with traditional contraindications to bariatric surgery were excluded. Patients who underwent bariatric surgery were identified and matched 1:2 with patients who did not undergo bariatric surgery based on age, sex, and comorbid conditions. Kaplan-Meier analysis and Cox proportional hazards modeling were used to evaluate differences in progression from NAFLD to cirrhosis.

RESULTS

A total of 2942 NAFLD patients who underwent bariatric surgery were identified and matched with 5884 NAFLD patients who did not undergo surgery. Cox proportional hazards modeling found that bariatric surgery was independently associated with a decreased risk of developing cirrhosis (hazard ratio 0.31, 95% confidence interval 0.19-0.52). Male gender was associated with an increased risk of cirrhosis (hazard ratio 2.07, 95% confidence interval 1.31-3.27).

CONCLUSIONS

Patients with NAFLD who undergo bariatric surgery are at a decreased risk for progression to cirrhosis compared to well-matched controls. Bariatric surgery should be considered as a treatment strategy for otherwise eligible patients with NAFLD. Future bariatric surgery guidelines should include NAFLD as a comorbid indication when determining eligibility.

摘要

目的

本研究旨在比较行减重手术与匹配良好的非手术对照组患者的非酒精性脂肪性肝病(NAFLD)患者肝硬化发展趋势。

背景资料概要

行减重手术的 NAFLD 患者通常其肝脏组织学得到改善。然而,减重手术对临床相关肝脏结局的长期影响尚未得到研究。

方法

从大型保险数据库中,确定了具有新的 NAFLD 诊断且在诊断前和诊断后至少有 2 年连续入组的患者。排除了具有减重手术传统禁忌证的患者。识别出接受减重手术的患者,并根据年龄、性别和合并症情况,与未接受减重手术的患者进行 1:2 匹配。采用 Kaplan-Meier 分析和 Cox 比例风险模型评估从 NAFLD 进展为肝硬化的差异。

结果

共确定了 2942 例接受减重手术的 NAFLD 患者,并与 5884 例未接受手术的 NAFLD 患者进行了匹配。Cox 比例风险模型发现,减重手术与肝硬化发生风险降低独立相关(风险比 0.31,95%置信区间 0.19-0.52)。男性与肝硬化风险增加相关(风险比 2.07,95%置信区间 1.31-3.27)。

结论

与匹配良好的对照组相比,行减重手术的 NAFLD 患者进展为肝硬化的风险降低。对于符合条件的其他 NAFLD 患者,应考虑将减重手术作为一种治疗策略。未来的减重手术指南在确定资格时应将 NAFLD 纳入合并症适应证。

相似文献

1
Bariatric Surgery is Associated With Decreased Progression of Nonalcoholic Fatty Liver Disease to Cirrhosis: A Retrospective Cohort Analysis.减重手术与非酒精性脂肪性肝病向肝硬化的进展减少相关:一项回顾性队列分析。
Ann Surg. 2020 Jul;272(1):32-39. doi: 10.1097/SLA.0000000000003871.
2
Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis.非酒精性脂肪性肝病的营养补充:一项网状Meta分析。
Cochrane Database Syst Rev. 2021 Jul 19;7(7):CD013157. doi: 10.1002/14651858.CD013157.pub2.
3
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
4
Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease.瞬时弹性成像技术用于诊断酒精性肝病患者的肝纤维化和肝硬化分期。
Cochrane Database Syst Rev. 2015 Jan 22;1(1):CD010542. doi: 10.1002/14651858.CD010542.pub2.
5
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.减肥手术治疗肥胖症的临床疗效和成本效益:一项系统评价与经济评估
Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410.
6
Surgical Hip Dislocation in the Era of Hip Arthroscopy Demonstrates High Survivorship and Improvements in Patient-reported Outcomes for Complex Femoroacetabular Impingement.关节镜时代的髋关节脱位手术具有高存活率,并改善了复杂型股骨髋臼撞击症患者的报告结局。
Clin Orthop Relat Res. 2024 Sep 1;482(9):1671-1682. doi: 10.1097/CORR.0000000000003032. Epub 2024 Mar 21.
7
Benefit-risk of intraoperative liver biopsy during bariatric surgery: review and perspectives.减重手术中肝活检的获益-风险:综述与展望。
Surg Obes Relat Dis. 2017 Oct;13(10):1780-1786. doi: 10.1016/j.soard.2017.07.032. Epub 2017 Aug 14.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.用于非酒精性脂肪性肝病和非酒精性脂肪性肝炎的他汀类药物。
Cochrane Database Syst Rev. 2013 Dec 27;2013(12):CD008623. doi: 10.1002/14651858.CD008623.pub2.
10
Bariatric Surgery is Effective and Safe for Obese Patients with Compensated Cirrhosis: A Systematic Review and Meta-Analysis.肥胖合并代偿期肝硬化患者行减重手术安全有效:系统评价和荟萃分析
World J Surg. 2022 May;46(5):1122-1133. doi: 10.1007/s00268-021-06382-z. Epub 2022 Mar 11.

引用本文的文献

1
Post-Metabolic Bariatric Surgery Cirrhosis and the Role of Liver Transplantation: A Report from a Referral Transplant Center.代谢性减重手术后肝硬化与肝移植的作用:来自一家转诊移植中心的报告
Obes Surg. 2025 May 9. doi: 10.1007/s11695-025-07852-2.
2
Sleep Disorders: Pathogenesis and Therapeutic Interventions.睡眠障碍:发病机制与治疗干预
MedComm (2020). 2025 Mar 10;6(3):e70130. doi: 10.1002/mco2.70130. eCollection 2025 Mar.
3
Therapeutic Targets and Approaches to Manage Inflammation of NAFLD.非酒精性脂肪性肝病炎症管理的治疗靶点与方法

本文引用的文献

1
Risk factors and prevalence of liver disease in review of 2557 routine liver biopsies performed during bariatric surgery.在对 2557 例行减肥手术中进行的常规肝活检进行回顾性研究中发现的肝病的风险因素和流行情况。
Surg Obes Relat Dis. 2019 Jun;15(6):843-849. doi: 10.1016/j.soard.2019.01.035. Epub 2019 Mar 20.
2
Weight Loss After Bariatric Surgery Predicts an Improvement in the Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score.减重手术后体重减轻可预测非酒精性脂肪性肝病(NAFLD)纤维化评分的改善。
Obes Surg. 2019 Apr;29(4):1295-1300. doi: 10.1007/s11695-018-03676-5.
3
Improvement in Non-alcoholic Fatty Liver Disease Score Correlates with Weight Loss in Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy: a Two-Centre Study from an Asian Cohort.
Biomedicines. 2025 Feb 6;13(2):393. doi: 10.3390/biomedicines13020393.
4
Impact of Weight Loss on Metabolic Dysfunction Associated Steatohepatitis and Hepatic Fibrosis.体重减轻对代谢功能障碍相关脂肪性肝炎和肝纤维化的影响。
Curr Diab Rep. 2025 Feb 18;25(1):23. doi: 10.1007/s11892-025-01579-1.
5
Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies.中西医结合防治非酒精性脂肪性肝病:未来方向与策略
Chin Med. 2024 Feb 3;19(1):21. doi: 10.1186/s13020-024-00894-1.
6
Impact of gastric bypass surgery on the liver fibrosis of patients with extreme obesity and nonalcoholic fatty liver disease in 30-month follow-up.胃旁路手术对极度肥胖和非酒精性脂肪性肝病患者肝纤维化的30个月随访影响
Updates Surg. 2023 Apr;75(3):659-669. doi: 10.1007/s13304-022-01421-3. Epub 2022 Dec 19.
7
Bariatric endoscopic-surgical therapies for NAFLD. Should they be considered viable options among current treatments?肥胖症内镜手术治疗非酒精性脂肪性肝病。在当前治疗方法中,它们是否应被视为可行的选择?
Front Endocrinol (Lausanne). 2022 Nov 29;13:1026444. doi: 10.3389/fendo.2022.1026444. eCollection 2022.
8
Gender Differences in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病中的性别差异
Euroasian J Hepatogastroenterol. 2022 Jul;12(Suppl 1):S19-S25. doi: 10.5005/jp-journals-10018-1370.
9
Comparative effectiveness of medical treatment metabolic surgery for histologically proven non-alcoholic steatohepatitis and fibrosis: a matched network meta-analysis.药物治疗与代谢手术对组织学确诊的非酒精性脂肪性肝炎和肝纤维化的比较疗效:一项配对网络荟萃分析。
Hepatobiliary Surg Nutr. 2022 Oct;11(5):696-708. doi: 10.21037/hbsn-21-5.
10
Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis.非酒精性脂肪性肝炎及其纤维化的发病机制与治疗。
Clin Mol Hepatol. 2023 Jan;29(1):77-98. doi: 10.3350/cmh.2022.0237. Epub 2022 Oct 13.
腹腔镜袖状胃切除术治疗肥胖患者的非酒精性脂肪肝疾病评分改善与体重减轻相关:来自亚洲队列的两项中心研究。
Obes Surg. 2019 Mar;29(3):862-868. doi: 10.1007/s11695-018-3581-5.
4
Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis.减重手术后非酒精性脂肪肝疾病的完全缓解:系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2019 May;17(6):1040-1060.e11. doi: 10.1016/j.cgh.2018.10.017. Epub 2018 Oct 13.
5
Effect of Body Mass Index, Metabolic Health and Adipose Tissue Inflammation on the Severity of Non-alcoholic Fatty Liver Disease in Bariatric Surgical Patients: a Prospective Study.肥胖指数、代谢健康和脂肪组织炎症对减重手术患者非酒精性脂肪性肝病严重程度的影响:一项前瞻性研究。
Obes Surg. 2019 Jan;29(1):99-108. doi: 10.1007/s11695-018-3479-2.
6
Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score).基于标准化 NAS(非酒精性脂肪性肝病活动评分),肥胖症患者在接受减重手术后其非酒精性脂肪性肝病的组织学改善。
Surg Obes Relat Dis. 2018 Oct;14(10):1607-1616. doi: 10.1016/j.soard.2018.07.012. Epub 2018 Jul 24.
7
The impact of clinical vs administrative claims coding on hospital risk-adjusted outcomes.临床编码与管理性索赔编码对医院风险调整后结果的影响。
Clin Cardiol. 2018 Sep;41(9):1225-1231. doi: 10.1002/clc.23059. Epub 2018 Sep 22.
8
Long-term effect of bariatric surgery on resolution of nonalcoholic steatohepatitis (NASH): An external validation and application of a clinical NASH score.减重手术对非酒精性脂肪性肝炎(NASH)缓解的长期影响:临床 NASH 评分的外部验证和应用。
Surg Obes Relat Dis. 2018 Oct;14(10):1600-1606. doi: 10.1016/j.soard.2018.05.024. Epub 2018 Jun 6.
9
Obesity and Weight Gain Are Associated With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.肥胖和体重增加与非酒精性脂肪性肝病患者肝纤维化进展相关。
Clin Gastroenterol Hepatol. 2019 Feb;17(3):543-550.e2. doi: 10.1016/j.cgh.2018.07.006. Epub 2018 Sep 11.
10
Validation of body mass index (BMI)-related ICD-9-CM and ICD-10-CM administrative diagnosis codes recorded in US claims data.验证美国索赔数据中与体重指数(BMI)相关的 ICD-9-CM 和 ICD-10-CM 行政诊断代码。
Pharmacoepidemiol Drug Saf. 2018 Oct;27(10):1092-1100. doi: 10.1002/pds.4617. Epub 2018 Jul 12.